PYCARD and cancer: showed similar methylation trends of PYCARD with 64% of methylation in high-grade PIN samples examined, 65% in cancer specimens, and 28% in the adjacent normal tissue, while all normal donor prostate samples presented unmethylated PYCARD promoter [114].